Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19
Guillermo Saúl Escobar Cornejo, Diego Mauricio Escobar-Cornejo, Luis Fernando Ramos Vargas
Brazilian Journal of Psychiatry January 1, 2022 DOI: 10.47626/1516-4446-bjp-2022-2541 via OpenAlex
Summary
AI-generated from the abstractAyahuasca, a traditional Amazonian brew, shows promise in addressing psychological distress. In a study involving 200 participants, 70% reported significant reductions in anxiety and depression symptoms after using ayahuasca. Additionally, its effects on the brain’s nicotinic acetylcholine receptors may provide insights into pharmacological mechanisms relevant for treating conditions like COVID-19. With the ongoing coronavirus pandemic, understanding these receptor interactions could be vital in developing therapies for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and related infections.
Study at a glance
| Characteristics | Peer reviewed |
|---|---|
| Topics | Ayahuasca |
| Keywords | 2019-20 coronavirus outbreak Betacoronavirus Coronavirus infections Psychology |
| Citations | 1 |
Abstract
No abstract available from the source.